Sanofi Australia has received
TGA approval for its Zaltrap
(aflibercept rch) in combination
chemotherapy for use in
adults with metastatic colorectal
cancer previously treated with an
oxaliplatin-containing regimen.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 05 Apr 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Apr 13
PHARMACISTS recruited by NSW Health, as part of a State Budget announcement, should be allocated to different areas of practice and “not just hospitals”, the Pharmaceutical Society of Australia (PSA) believes.